Behandeling met radioactief jodium versus hemithyreoïdectomie, welke behandeling heeft het beste effect heeft op klachten bij patiënten met symptomatisch euthyreoot struma

Authors
Category Primary study
Registry of TrialsNetherlands Trial Register
Year 2018
INTERVENTION: Radioactive iodine treatment Hemithyroidectomy CONDITION: Euthyroidism, Radioactive iodine, Goiter, Benign euthyroid goitre ; ; PRIMARY OUTCOME: reduction of symptoms 12 months after treatment measured with ThyPro Questionnaire SECONDARY OUTCOME: ‐ Quality of life measured by EQ‐5D‐5L questionnaire after 6 months and 1‐5 years ; ; ‐ Voice impairment after 6 months and 1‐5 years as measured by the Voice Handicap ; Index, a specific questionnaire for voice impairment detection a ; ; ‐ Effect of treatment on symptoms after 6 months, 2, 3, 4 and 5 years after treatment ; as measurd by the ThyPRO questionnairre ; ; ‐ Goitre volume as measured on a CT‐scan 12 months after treatment ; ; ‐ Serum TSH, T4 levels, PTH (standard 2‐6 weeks after treatment or if measured under ; routine care at any time during follow‐up) ; ; ‐ Hypo‐ or hyperthyroidism ; ; ‐ Peri‐operative complications: vocal cords palsy ; ; ‐ Complications of radioactive iodine INCLUSION CRITERIA: ‐ Patients with symptomatic goitre ‐ Goitre size larger than 40 ml on one side determined on CT ‐ Patients accept both treatment modalities ‐ TSH between 0,5‐5,0 mE/L (euthyroidism) without Thyroid suppletion ‐ Not pregnant or childwish within 6 months after treatment ‐ Able to undergo surgery as well as radioiodine treatment ‐ 18 years or older
Epistemonikos ID: 03791d56703cd8c6aaae2e7e5d98440c012f1513
First added on: Aug 24, 2024